GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acasti Pharma Inc (TSXV:ACST) » Definitions » Sale Of Property, Plant, Equipment

Acasti Pharma (TSXV:ACST) Sale Of Property, Plant, Equipment : C$0.00 Mil (TTM As of Dec. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Acasti Pharma Sale Of Property, Plant, Equipment?

Acasti Pharma's sale of property, plant, equipment for the three months ended in Dec. 2024 was C$0.00 Mil. It means Acasti Pharma gained C$0.00 Mil from selling property, plant, and equipment. Acasti Pharma's sale of property, plant, equipment for the trailing twelve months (TTM) ended in Dec. 2024 was C$0.00 Mil.

Compared with last quarter (C$0.00 Mil in Sep. 2024 ), Acasti Pharma gained the same money from selling property, plant, and equipment in Dec. 2024 (C$0.00 Mil).

Acasti Pharma Sale Of Property, Plant, Equipment Historical Data

The historical data trend for Acasti Pharma's Sale Of Property, Plant, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acasti Pharma Sale Of Property, Plant, Equipment Chart

Acasti Pharma Annual Data
Trend Feb14 Feb15 Feb16 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Sale Of Property, Plant, Equipment
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.15

Acasti Pharma Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Sale Of Property, Plant, Equipment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Acasti Pharma Sale Of Property, Plant, Equipment Calculation

The amount earned to sell PPE.

Sale Of Property, Plant, Equipment for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Acasti Pharma Sale Of Property, Plant, Equipment Related Terms

Thank you for viewing the detailed overview of Acasti Pharma's Sale Of Property, Plant, Equipment provided by GuruFocus.com. Please click on the following links to see related term pages.

Acasti Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acasti Pharma Inc (TSXV:ACST) » Definitions » Sale Of Property, Plant, Equipment
Comparable Companies
FGEN ANVS HRGN PLUR COEP CASI ESLA BOLD LEXX AKTX VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
GRCE:USA
Address
103 Carnegie Center, Suite 300, Princeton, NJ, USA, 08540
Website
https://www.acastipharma.com
Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage.
Executives
Donald John Olds Director
Jean-françois Boily Senior Officer
Jean-marie Canan Director

Acasti Pharma Headlines

No Headlines